Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

This study has been terminated.
Information provided by (Responsible Party):
Mirati Therapeutics Inc. Identifier:
First received: July 31, 2006
Last updated: June 5, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 5, 2015